Skip to main content
Center for Disease Dynamics, Economics & Policy (CDDEP)
Enter your keywords
Disease Control Priorities
Alcohol and Tobacco
Health and Development
Where We Work
Global Antibiotic Resistance Partnership
Extending the Cure
Disease Control Priorities Network (DCPN)
Learning from the Bottom Billion
Pneumococcal Modeling Project (PneuMOD)
Influence of provider and urgent care density across different socioeconomic strata...
GARPNet News Vol. 1 Issue 1
Sex-selective Abortion Bans are Not Associated with Changes in Sex Ratios at Birth...
Economic burden of antibiotic resistance: how much do we really know?
Interactive data visualizations of antibiotic use and resistance in North America and Europe
Consumption of select key retail antibiotics in the United States and India in 2010
U.S. Congressional Legislation Relating to Antibiotic Use, 2004-2014
New Molecular Entity (NME) Systemic Antibiotics Approved by the FDA 1980-2009, but Subsequently Withdrawn or Discontinued
Ramanan Laxminarayan TEDMED Talk: Conserving Antibiotics as a Natural Resource
News & Blog
Weekly Digest: White House calls for $1.2 billion in antibiotic resistance funding
Weekly Digest: Measles in California, Ebola cases decline, genetics of malaria drug resistance
Does physician competition drive up antibiotic prescribing?
Part 2: Q&A with GARP-Kenya Coordinator Eveline Wesangula
Board of Directors
Media & Press
CDDEP In the News
Working at CDDEP
Annual Reports and Filings
You are here